Successful crizotinib monotherapy in EGFR-mutant lung adenocarcinoma with acquired MET amplification after erlotinib therapy

by Katsuhiro Yoshimura, MD, Naoki Inui, MD, PhD, Masato Karayama, MD, PhD, Yusuke Inoue, MD, Noriyuki Enomoto, MD, PhD, Tomoyuki Fujisawa, MD, PhD, Yutaro Nakamura, MD, PhD, Kengo Takeuchi, MD, PhD, Haruhiko Sugimura, MD, PhD, Takafumi Suda, MD, PhD
Published 2017-01-01